{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:40:17Z","timestamp":1792644017490,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["ZYGD25002"],"award-info":[{"award-number":["ZYGD25002"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82425054"],"award-info":[{"award-number":["82425054"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273784"],"award-info":[{"award-number":["82273784"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82607265"],"award-info":[{"award-number":["82607265"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["2025HXBH107"],"award-info":[{"award-number":["2025HXBH107"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD1801602"],"award-info":[{"award-number":["2025ZD1801602"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD0214904"],"award-info":[{"award-number":["2025ZD0214904"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2023ZYD0168"],"award-info":[{"award-number":["2023ZYD0168"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024NSFSC0048"],"award-info":[{"award-number":["2024NSFSC0048"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119379","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:55:22Z","timestamp":1790434522000},"page":"119379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of novel dual \u03bcOR\/\u03c31R ligands as potent analgesics with reduced tolerance liability and improved safety profiles"],"prefix":"10.1016","volume":"320","author":[{"given":"Menglan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kequan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2026.119379_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/bja\/81.1.58","article-title":"Opioid tolerance: the clinical perspective","volume":"81","author":"Collett","year":"1998","journal-title":"Br. J. Anaesth."},{"issue":"10180","key":"10.1016\/j.ejmech.2026.119379_bib2","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0140-6736(19)30430-1","article-title":"Perioperative opioid analgesia-when is enough too much? A review of opioid-induced tolerance and hyperalgesia","volume":"393","author":"Colvin","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119379_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJMra1800222","article-title":"Opioid tolerance in critical illness","volume":"380","author":"Martyn","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119379_bib4","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/bph.15580","article-title":"Understanding and countering opioid-induced respiratory depression","volume":"180","author":"Bateman","year":"2023","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119379_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.789","article-title":"Addressing opioid tolerance and opioid-induced hypersensitivity: recent developments and future therapeutic strategies","volume":"9","author":"Khan","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119379_bib6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and opioid-involved overdose deaths \u2014 united States, 2017\u20132018","volume":"69","author":"Wilson","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119379_bib7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the er-mitochondrion interface regulate Ca2+ signaling and cell survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.ejmech.2026.119379_bib8","doi-asserted-by":"crossref","first-page":"15187","DOI":"10.1021\/acs.jmedchem.0c01192","article-title":"Small molecules selectively targeting sigma-1 receptor for the treatment of neurological diseases","volume":"63","author":"Ye","year":"2020","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119379_bib9","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1021\/acs.jmedchem.5b01416","article-title":"Synthesis and biological evaluation of novel \u03c31 receptor ligands for treating neuropathic pain: 6-hydroxypyridazinones","volume":"59","author":"Cao","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119379_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115178","article-title":"2,6-diazaspiro[3.4]octan-7-one derivatives as potent sigma-1 receptor antagonists that enhanced the antinociceptive effect of morphine and rescued morphine tolerance","volume":"249","author":"Fu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119379_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173825","article-title":"Haloperidol potentiates antinociceptive effects of morphine and disrupt opioid tolerance","volume":"893","author":"Mena-Vald\u00e9s","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119379_bib12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1089\/ars.2014.5993","article-title":"The \u03c31 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control","volume":"22","author":"Rodr\u00edguez-Mu\u00f1oz","year":"2015","journal-title":"Antioxid. Redox Signaling"},{"issue":"1\u20133","key":"10.1016\/j.ejmech.2026.119379_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2013.04.018","article-title":"Sigma-1 receptor antagonism as opioid adjuvant strategy: enhancement of opioid antinociception without increasing adverse effects","volume":"711","author":"Vidal-Torres","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"20","key":"10.1016\/j.ejmech.2026.119379_bib14","doi-asserted-by":"crossref","first-page":"8881","DOI":"10.1021\/acs.jmedchem.9b00017","article-title":"Rational design of multitarget-directed ligands: strategies and emerging paradigms","volume":"62","author":"Zhou","year":"2019","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.ejmech.2026.119379_bib15","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1021\/jm5006463","article-title":"Polypharmacology: challenges and opportunities in drug discovery","volume":"57","author":"Anighoro","year":"2014","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119379_bib16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/acs.jmedchem.8b00760","article-title":"Polypharmacology by design: a medicinal chemist's perspective on multitargeting compounds","volume":"62","author":"Proschak","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119379_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149547","article-title":"Thiophenpiperazine amide derivatives as new dual MOR and \u03c31R ligands for the treatment of pain","volume":"697","author":"Fan","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"14","key":"10.1016\/j.ejmech.2026.119379_bib18","doi-asserted-by":"crossref","first-page":"10139","DOI":"10.1021\/acs.jmedchem.1c00417","article-title":"Propionamide derivatives as dual \u03bc-opioid receptor agonists and \u03c31 receptor antagonists for the treatment of pain","volume":"64","author":"Garc\u00eda","year":"2021","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.ejmech.2026.119379_bib19","doi-asserted-by":"crossref","first-page":"15508","DOI":"10.1021\/acs.jmedchem.0c01127","article-title":"Discovery of EST73502, a dual \u03bc-opioid receptor agonist and \u03c31 receptor antagonist clinical candidate for the treatment of pain","volume":"63","author":"Garc\u00eda","year":"2020","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119379_bib20","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1021\/acs.jmedchem.9b01256","article-title":"4-aryl-1-oxa-4,9-diazaspiro[5.5]undecane derivatives as dual \u03bc-opioid receptor agonists and \u03c31 receptor antagonists for the treatment of pain","volume":"63","author":"Garc\u00eda","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119379_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107921","article-title":"Benzylpiperidine derivatives as new dual \u03bc-opioid and \u03c31 receptor ligands with potent antinociceptive effects","volume":"153","author":"Li","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2026.119379_bib22","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.3390\/molecules27165135","article-title":"Novel N-normetazocine derivatives with opioid agonist\/sigma-1 receptor antagonist profile as potential analgesics in inflammatory pain","volume":"27","author":"Turnaturi","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119379_bib23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.apsb.2022.09.018","article-title":"Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids","volume":"13","author":"Vidal-Torres","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.119379_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112144","article-title":"Piperidine propionamide as a scaffold for potent sigma-1 receptor antagonists and mu opioid receptor agonists for treating neuropathic pain","volume":"191","author":"Xiong","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119379_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113879","article-title":"Optimization of bifunctional piperidinamide derivatives as \u03c31R antagonists\/MOR agonists for treating neuropathic pain","volume":"226","author":"Xiong","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119379_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114649","article-title":"Benzylaminofentanyl derivates: discovery of bifunctional \u03bc opioid and \u03c31 receptor ligands as novel analgesics with reduced adverse effects","volume":"241","author":"Zhuang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2026.119379_bib27","doi-asserted-by":"crossref","first-page":"16257","DOI":"10.1021\/acs.jmedchem.3c01637","article-title":"A novel bifunctional \u03bcOR agonist and \u03c31R antagonist with potent analgesic responses and reduced adverse effects","volume":"66","author":"Miao","year":"2023","journal-title":"J. Med. Chem."},{"issue":"Pt 17","key":"10.1016\/j.ejmech.2026.119379_bib28","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1113\/jphysiol.2010.194670","article-title":"Revealing the structural basis of action of hERG potassium channel activators and blockers","volume":"588","author":"Perry","year":"2010","journal-title":"J. Physiol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119379_bib29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1124\/mol.104.000117","article-title":"Structural determinants of hERG channel block by clofilium and ibutilide","volume":"66","author":"Perry","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"15","key":"10.1016\/j.ejmech.2026.119379_bib30","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1021\/acs.jmedchem.9b00891","article-title":"Discovery of 3,4,6-trisubstituted piperidine derivatives as orally active, low hERG blocking Akt inhibitors via conformational restriction and structure-based design","volume":"62","author":"Dong","year":"2019","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.ejmech.2026.119379_bib31","doi-asserted-by":"crossref","first-page":"13240","DOI":"10.1021\/acs.jmedchem.2c01064","article-title":"Structure-based optimization of coumestan derivatives as polyketide synthase 13-thioesterase(Pks13-TE) inhibitors with improved hERG profiles for mycobacterium tuberculosis treatment","volume":"65","author":"Zhang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119379_bib32","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.1021\/acs.jmedchem.4c02635","article-title":"Structure-based development of 3,4-fused tricyclic benzofuran derivatives as polyketide synthase 13 inhibitors with negligible hERG inhibition","volume":"68","author":"Zhou","year":"2025","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119379_bib33","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1021\/acs.jmedchem.9b00449","article-title":"Synthesis and structure-affinity relationships of spirocyclic benzopyrans with exocyclic amino moiety","volume":"62","author":"Kronenberg","year":"2019","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119379_bib34","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1021\/jm010992z","article-title":"Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1","volume":"45","author":"Maier","year":"2002","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2026.119379_bib35","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1021\/jm020889p","article-title":"Novel sigma receptor ligands. Part 2. Sar of spiro[[2]benzopyran-1,4'-piperidines] and spiro[[2]benzofuran-1,4'-piperidines] with carbon substituents in position 3","volume":"45","author":"Maier","year":"2002","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119379_bib36","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41589-022-01208-y","article-title":"Insights into distinct signaling profiles of the \u03bcOR activated by diverse agonists","volume":"19","author":"Qu","year":"2023","journal-title":"Nat. Chem. Biol."},{"issue":"16","key":"10.1016\/j.ejmech.2026.119379_bib37","doi-asserted-by":"crossref","first-page":"11447","DOI":"10.1021\/acs.jmedchem.3c00959","article-title":"Discovery of AD258 as a sigma receptor ligand with potent antiallodynic activity","volume":"66","author":"Dichiara","year":"2023","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119379_bib38","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1021\/acs.jmedchem.0c01964","article-title":"Novel sigma 1 receptor antagonists as potential therapeutics for pain management","volume":"64","author":"Peng","year":"2021","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119379_bib39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/syn.20103","article-title":"Phenytoin differentially modulates the affinity of agonist and antagonist ligands for sigma 1 receptors of Guinea pig brain","volume":"55","author":"Cobos","year":"2005","journal-title":"Synapse"},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2026.119379_bib40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0014-2999(84)90374-1","article-title":"Comparative antagonism by naltrexone and naloxone of \u03bc, \u03ba, and \u03b4 agonists","volume":"104","author":"Takemori","year":"1984","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119379_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/jpet.113.208272","article-title":"Modulation of peripheral \u03bc-opioid analgesia by \u03c31 receptors","volume":"348","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2014","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2026.119379_bib42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neubiorev.2017.09.022","article-title":"Opioid-induced rewards, locomotion, and dopamine activation: a proposed model for control by mesopontine and rostromedial tegmental neurons","volume":"83","author":"Steidl","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119379_bib43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/ph4020233","article-title":"Pharmacological evaluation of 3-carbomethoxy fentanyl in mice","volume":"4","author":"Vuckovic","year":"2011","journal-title":"Pharmaceuticals"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119379_bib44","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/bph.13489","article-title":"BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice","volume":"173","author":"Li","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119379_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/bph.14848","article-title":"The multifunctional peptide DN-9 produced peripherally acting antinociception in inflammatory and neuropathic pain via \u03bc- and \u03ba-opioid receptors","volume":"177","author":"Xu","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119379_bib46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.str.2020.12.007","article-title":"Cryo-EM structure of k+-bound hERG channel complexed with the blocker astemizole","volume":"29","author":"Asai","year":"2021","journal-title":"Structure"},{"issue":"22","key":"10.1016\/j.ejmech.2026.119379_bib47","doi-asserted-by":"crossref","first-page":"12329","DOI":"10.1073\/pnas.210244497","article-title":"A structural basis for drug-induced long QT syndrome","volume":"97","author":"Mitcheson","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119379_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600824X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600824X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:22:38Z","timestamp":1792642958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342600824X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":48,"alternative-id":["S022352342600824X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119379","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel dual \u03bcOR\/\u03c31R ligands as potent analgesics with reduced tolerance liability and improved safety profiles","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119379"}}